Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 16 Nov 2021

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

in Hematologic Malignancies

Hong-Hu Zhu
Ya-Fang Ma
Kang Yu
Gui-Fang Ouyang
Wen-Da Luo
Ren-Zhi Pei
Wei-Qun Xu
Hui-Xian Hu
Shu-Ping Mo
Xiao-Hua Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.762653

9,549 views
23 citations

Review

Published on 16 Nov 2021

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview

in Hematologic Malignancies

Andrea Kuendgen
Annika Kasprzak
Ulrich Germing

Frontiers in Oncology

doi 10.3389/fonc.2021.778741

7,845 views
8 citations

Original Research

Published on 12 Nov 2021

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia

in Hematologic Malignancies

Mingyue Shi
Junwei Niu
Xiaona Niu
Honggang Guo
Yanliang Bai
Jie Shi
Weiya Li
Kai Sun
Yuqing Chen
Fengmin Shao

Frontiers in Oncology

doi 10.3389/fonc.2021.763232

4,361 views
14 citations

Review

Published on 11 Nov 2021

Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors

in Hematologic Malignancies

Chrysi Galigalidou
Laura Zaragoza-Infante
Anastasia Iatrou
Anastasia Chatzidimitriou
Kostas Stamatopoulos
Andreas Agathangelidis

Frontiers in Oncology

doi 10.3389/fonc.2021.769612

33,574 views
19 citations

Review

Published on 11 Nov 2021

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia

in Hematologic Malignancies

Diletta Fontana
Carlo Gambacorti-Passerini
Rocco Piazza

Frontiers in Oncology

doi 10.3389/fonc.2021.756348

8,479 views
9 citations

Review

Published on 10 Nov 2021

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma

in Hematologic Malignancies

Fatih M. Uckun

Frontiers in Oncology

doi 10.3389/fonc.2021.760382

6,990 views
14 citations

Review

Published on 10 Nov 2021

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies

in Hematologic Malignancies

Mojdeh Soltani
Yue Zhao
Zhijia Xia
Mazdak Ganjalikhani Hakemi
Alexandr V. Bazhin

Frontiers in Oncology

doi 10.3389/fonc.2021.767026

13,436 views
57 citations

Original Research

Published on 09 Nov 2021

Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data

in Hematologic Malignancies

Akanksha Farswan
Anubha Gupta
Krishnamachari Sriram
Atul Sharma
Lalit Kumar
Ritu Gupta

Frontiers in Oncology

doi 10.3389/fonc.2021.720932

4,421 views
12 citations

Perspective

Published on 08 Nov 2021

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

in Hematologic Malignancies

Susan M. O’Brien
Jennifer R. Brown
John C. Byrd
Richard R. Furman
Paolo Ghia
Jeff P. Sharman
William G. Wierda

Frontiers in Oncology

doi 10.3389/fonc.2021.720704

28,788 views
59 citations

Case Report

Published on 08 Nov 2021

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

in Hematologic Malignancies

Chao Chen
Wei Zhang
Daobin Zhou
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.757403

3,391 views
9 citations

Mini Review

Published on 05 Nov 2021

Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications

in Hematologic Malignancies

John M. Astle
Huiya Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.704464

5,845 views
11 citations

Original Research

Published on 05 Nov 2021

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities

in Hematologic Malignancies

Carmen-Mariana Aanei
Richard Veyrat-Masson
Cristina Selicean
Mirela Marian
Lauren Rigollet
Adrian Pavel Trifa
Ciprian Tomuleasa
Adrian Serban
Mohamad Cherry
Pascale Flandrin-Gresta

Frontiers in Oncology

doi 10.3389/fonc.2021.746951

7,334 views
7 citations

Brief Research Report

Published on 05 Nov 2021

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

in Hematologic Malignancies

Guido Gini
Alice Di Rocco
Luca Nassi
Annalisa Arcari
Maria Chiara Tisi
Giacomo Loseto
Attilio Olivieri
Massimo Gentile
Ombretta Annibali
Maria Giuseppina Cabras

Frontiers in Oncology

doi 10.3389/fonc.2021.730194

4,492 views

Original Research

Published on 04 Nov 2021

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

in Hematologic Malignancies

Weiping Liu
Donglu Zhao
Ting Liu
Ting Niu
Yongping Song
Wei Xu
Jie Jin
Qingqing Cai
Huiqiang Huang
Zhiming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.750323

10,697 views
23 citations

Original Research

Published on 04 Nov 2021

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

in Hematologic Malignancies

Rui Liu
Ying Shen
Jinsong Hu
Xiaman Wang
Dong Wu
Meng Zhai
Ju Bai
Aili He

Frontiers in Oncology

doi 10.3389/fonc.2021.731957

5,657 views
9 citations

Original Research

Published on 03 Nov 2021

Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

in Hematologic Malignancies

Ziyuan Shen
Ling Wang
Bingpei Zhang
Tianci Li
Dashan Li
Chenlu He
Yuhao Xue
Ying Wang
Bingzong Li
Qinhua Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.754180

4,615 views
5 citations

Mini Review

Published on 03 Nov 2021

Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

in Hematologic Malignancies

Marina Gerousi
Stamatia Laidou
Katerina Gemenetzi
Kostas Stamatopoulos
Anastasia Chatzidimitriou

Frontiers in Oncology

doi 10.3389/fonc.2021.771454

5,928 views
15 citations

Brief Research Report

Published on 01 Nov 2021

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

in Hematologic Malignancies

Lijuan Ding
Yiyun Wang
Ruimin Hong
Houli Zhao
Linghui Zhou
Guoqing Wei
Wenjun Wu
Huijun Xu
Yanlei Zhang
Yi Luo

Frontiers in Oncology

doi 10.3389/fonc.2021.750218

5,031 views
11 citations

Review

Published on 29 Oct 2021

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

in Hematologic Malignancies

Carlos Cuesta-Mateos
Fernando Terrón
Marco Herling

Frontiers in Oncology

doi 10.3389/fonc.2021.736758

9,918 views
23 citations

Review

Published on 29 Oct 2021

Recent Progress in Interferon Therapy for Myeloid Malignancies

in Hematologic Malignancies

Fiona M. Healy
Lekh N. Dahal
Jack R.E. Jones
Yngvar Floisand
John F. Woolley

Frontiers in Oncology

doi 10.3389/fonc.2021.769628

10,237 views
17 citations

Brief Research Report

Published on 28 Oct 2021

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study

in Hematologic Malignancies

Xuejun Alice Wang
Adam F. Binder
Usama Gergis
Lindsay Wilde

Frontiers in Oncology

doi 10.3389/fonc.2021.740320

3,373 views
8 citations

Original Research

Published on 28 Oct 2021

Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin’s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation

in Hematologic Malignancies

Jiaqian Qi
Chengyuan Gu
Weijuan Wang
Mengqi Xiang
Xiaochen Chen
Jianhong Fu

Frontiers in Oncology

doi 10.3389/fonc.2021.753712

43,201 views
23 citations

Review

Published on 28 Oct 2021

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells

in Hematologic Malignancies

Yilin Chen
Jing Zou
Fanjun Cheng
Weiming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.769730

9,925 views
26 citations

Review

Published on 28 Oct 2021

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective

in Hematologic Malignancies

Ying-Jun Chang
Xiang-Yu Zhao
Xiao-Jun Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.758512

15,882 views
18 citations

2,071 articles

articles

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia

Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies

Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

Recent Progress in Interferon Therapy for Myeloid Malignancies

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study

Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin’s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective